Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Assunto da revista
Intervalo de ano de publicação
1.
Drug Chem Toxicol ; 32(2): 103-7, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19514945

RESUMO

The correlations between the presence of MTHFR 677 (C>T) and MTHFR 1298 (A>C) mutations in human lymphocytes and the sensitivity of lymphocytes to methotrexate (MTX) were examined in cultures derived from 82 unrelated women, genotyped for these mutations by polymerase chain reaction-restriction fragment length polymorphism. Lymphocytes heterozygous for the mutant allele, MTHFR 677T, were significantly more sensitive to methotrexate than those carrying the homozygous wild-type allele, MTHFR677C, and those carrying either the mutant or the wild-type alleles in the polymorphic MTHFR 1298 site. In addition, the lymphocyte cultures carrying the mutant MTHFR 1298C allele were not different in their sensitivity to MTX from those cultures carrying the wild-type allele, MTHFR 1298A. This demonstrated that the polymorphic site MTHFR C677, but not MTHFR1298, could be considered as a useful pharmacogenetic determinant in planning and designing the effective personal MTX chemotherapeutic doses and regimes.


Assuntos
Linfócitos/efeitos dos fármacos , Metotrexato/farmacologia , Metilenotetra-Hidrofolato Redutase (NADPH2)/genética , Sensibilidade e Especificidade , Alelos , Antirreumáticos/farmacologia , Drogas Desenhadas/uso terapêutico , Relação Dose-Resposta a Droga , Ensaios de Seleção de Medicamentos Antitumorais , Tratamento Farmacológico/métodos , Feminino , Predisposição Genética para Doença , Genótipo , Humanos , Linfócitos/fisiologia , Mutação , Farmacogenética , Polimorfismo Genético , Polimorfismo de Nucleotídeo Único , Células Tumorais Cultivadas
2.
J Appl Physiol (1985) ; 93(2): 450-6, 2002 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12133849

RESUMO

The role of endogenous nitric oxide (NO) in modulating the excitatory response of distal airways to vagal stimulation is unknown. In decerebrate, ventilated, open-chest piglets aged 3-10 days, lung resistance (RL) was partitioned into tissue resistance (Rti) and airway resistance (Raw) by using alveolar capsules. Changes in RL, Rti, and Raw were evaluated during vagal stimulation at increasing frequency before and after NO synthase blockade with N(omega)-nitro-L-arginine methyl ester (L-NAME). Vagal stimulation increased RL by elevating both Rti and Raw. NO synthase blockade significantly increased baseline Rti, but not Raw, and significantly augmented the effects of vagal stimulation on both Rti and Raw. Vagal stimulation also resulted in a significant increase in cGMP levels in lung tissue before, but not after, L-NAME infusion. In seven additional piglets after RL was elevated by histamine infusion in the presence of cholinergic blockade with atropine, vagal stimulation failed to elicit any change in RL, Rti, or Raw. Therefore, endogenous NO not only plays a role in modulating baseline Rti, but it opposes the excitatory cholinergic effects on both the tissue and airway components of RL. We speculate that activation of the NO/cGMP pathway during cholinergic stimulation plays an important role in modulating peripheral as well as central contractile elements in the developing lung.


Assuntos
Resistência das Vias Respiratórias/fisiologia , Óxido Nítrico/metabolismo , Nervo Vago/fisiologia , Resistência das Vias Respiratórias/efeitos dos fármacos , Animais , Atropina/farmacologia , Broncodilatadores/farmacologia , Fibras Colinérgicas/fisiologia , GMP Cíclico/metabolismo , Estimulação Elétrica , Inibidores Enzimáticos/farmacologia , Feminino , Histamina/farmacologia , Masculino , NG-Nitroarginina Metil Éster/farmacologia , Óxido Nítrico Sintase/antagonistas & inibidores , Óxido Nítrico Sintase/metabolismo , Suínos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA